This is the first and only conference exclusively focusing on ADC payloads, helping you to reimagine the medicinal chemistry of ...
The 3rd Obesity & Weight Loss Drug Development Summit is the place to be for experts in weight loss drug development tackling ...
A digital therapeutic (DTx) for attention deficit hyperactivity disorder (ADHD) developed by Akili has been approved in Japan ...
Bullous pemphigoid (BP), which has no FDA-approved targeted therapies, leads to reddening of the skin and the formation of ...
Four more experimental drugs for amyotrophic lateral sclerosis (ALS) have failed to hit the primary endpoint in the phase 2/3 ...
The biosimilars reach the US market as the US insulin space has seen seismic changes in the last few years, with a clamour of ...
The text of the bill is vanishingly short and does not give any indication of the drugs that might be prescribed by AIs or ...
This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...
TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...
These have been dark days for the global economy, and the short-term prospects for the pharmaceutical industry look uncertain. The industry is currently undergoing change and restructuring on an ...
The 6th Cytokine-Based Drug Development Summit (May 15-16 in Boston) returns as the only industry focused conference that ...
As a bonus, Bavarian Nordic also gets a priority review voucher from the FDA, awarded as an incentive to carry out drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results